On March 12 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On March 11 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On March 8 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration on March 8 ended a ban on imports of genetically engineered salmon, deactivating Import Alert 99-40 to allow the sale and importation of AquaBounty Technologies’ AquAdvantage Salmon, the only currently approved GE salmon for food use, it said in a “questions and answers” page recently added to the FDA website. The move follows regulations recently issued by the Agricultural Marketing Service setting disclosure requirements for GE foods and set to take effect in 2022 (see 1812260052). Congress had in 2016 directed FDA to ban imports of GE salmon until a labeling standard was developed, a requirement FDA deemed satisfied with the issuance of USDA’s final rule. “FDA intends to revise” agency guidance for “food manufacturers who wish to voluntarily label their food products or ingredients (for humans or animals) derived from Atlantic salmon as not containing GE Atlantic salmon,” it said.
On March 7 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On March 6 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration issued its weekly Enforcement Report for March 6 that lists the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
On March 5 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration on March 6 announced an updated draft guidance document on mitigation strategies to protect food against intentional adulteration. Once finalized, the guidance will assist in compliance with regulations issued in 2016 requiring food facilities to implement defense measures against acts of terrorism (see 1605260013). The new version replaces an initial draft issued by FDA in 2018 (see 1806220016). A new chapter addresses education and training, and the updated version also has new sections of the existing chapter on vulnerability assessments on evaluation, identifying vulnerabilities and identifying actionable process steps. Comments on the revised draft guidance are due July 5.
On March 4 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of: